Trial Profile
A Phase 2 Trial of BN-Brachyury and Radiation Therapy in Patients With Advanced Chordoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2023
Price :
$35
*
At a glance
- Drugs MVA brachyury TRICOM vaccine (Primary)
- Indications Chordoma
- Focus Proof of concept; Therapeutic Use
- Sponsors Bavarian Nordic
- 25 Feb 2022 Status changed from active, no longer recruiting to completed.
- 27 Jul 2021 Planned End Date changed from 1 Apr 2022 to 1 Jan 2022.
- 27 Jul 2021 Planned primary completion date changed from 1 Jan 2021 to 10 Dec 2021.